Trends in global API manufacturing and strategic success in regulatory affairs
This webinar organized in collaboration Indian Drug Manufacturers’ Association (IDMA) and Bulk Drug Manufacturers’ Association India (BDMA) covers two major topics.
Trends in global API manufacturing
In the first topic we focus on an overview of the global API industry taking a deep dive into where top API manufacturers are located, their capabilities, and proficiency in specific product classes.
We also look at the impact COVID-19 has had on supply chains and the API manufacturing industry, and provide tips to identify and evaluate potential portfolio candidates based on industry needs and trends.
What is the key to strategic success in regulatory affairs?
In the second topic we talk about how to unlock a well-defined, multinational regulatory strategy. The pandemic has created many unforeseen challenges in adapting regulatory strategies to meet the needs of the day. Without a sound strategy, you’ll struggle to get your life saving treatment approved and to patients. This limits both patient access to medicines your company creates as well as limiting commercial success.
Educating your regulatory affairs (RA) team and aligning your regulatory strategy across critical functions is key to driving success. By breaking down the process into manageable chunks, your RA team can take the lead in crafting a robust strategy interlinked with competitive analysis.
In this webinar, gather a deeper understanding of the global API industry and uncover how you can design your regulatory strategy efficiently and confidently.